257 related articles for article (PubMed ID: 4140703)
1. [L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease].
Letonturier P; Tourneur R; Sénécal P
Ann Med Interne (Paris); 1974 May; 125(5):463-7. PubMed ID: 4140703
[No Abstract] [Full Text] [Related]
2. [Familial Basedow's disease in 3 generations].
Gilbert-Dreyfus ; Peillon F; Doucet D
Ann Med Interne (Paris); 1972 Nov; 123(11):937-40. PubMed ID: 4679054
[No Abstract] [Full Text] [Related]
3. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
Silverstein GE; Burke G
Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
[No Abstract] [Full Text] [Related]
4. Radioimmunological studies on the long-acting thyroid stimulator.
Pinchera A; Rovis L; Grasso L; Liberti P; Martino E; Fenzi GF; Baschieri L
Endocrinology; 1970 Aug; 87(2):217-25. PubMed ID: 4193237
[No Abstract] [Full Text] [Related]
5. [Hyperthyreosis in Basedow's disease].
Välimäki MJ
Duodecim; 1998; 114(5):447-54. PubMed ID: 11466937
[No Abstract] [Full Text] [Related]
6. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
[TBL] [Abstract][Full Text] [Related]
7. [Etiology of Basedow's disease, with special reference to LATS].
Nagata K
Naika Hokan; 1969 Jul; 16(7):297-317. PubMed ID: 4901097
[No Abstract] [Full Text] [Related]
8. Large doses of radioiodide in Graves' disease: effect on ophthalmopathy and long-acting thyroid stimulator.
Pequegnat EP; Mayberry WE; McConahey WM; Wyse EP
Mayo Clin Proc; 1967 Dec; 42(12):802-11. PubMed ID: 4169552
[No Abstract] [Full Text] [Related]
9. [Simultaneous study of LATS and antimicrosomial antibodies in untreated Basedow's disease].
Orgiazzi J; Pousset G; Durand H
Presse Med (1893); 1971 May; 79(25):1167-8. PubMed ID: 4933634
[No Abstract] [Full Text] [Related]
10. [Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
Tourneur R; Letonturier P; Sénécal P
MMW Munch Med Wochenschr; 1974 Mar; 116(13):677-9. PubMed ID: 4212576
[No Abstract] [Full Text] [Related]
11. Complex investigation of Graves'-Basedow disease: case report.
Luca IC; Bene MC; Cotuţiu C
Rev Med Chir Soc Med Nat Iasi; 1997; 101(3-4):202-4. PubMed ID: 10756799
[TBL] [Abstract][Full Text] [Related]
12. Mitotic index in toxic diffuse goitres.
Nilsson G
Ann Clin Res; 1974 Jun; 6(3):142-5. PubMed ID: 4407913
[No Abstract] [Full Text] [Related]
13. [Combination of low doses of 131-iodine and synthetic antithyroid agents for prolonged treatment in Basedow's disease. Apropos of 165 cases].
Mitouze J; Jaffiol C; Baldet L; Ghachem M
Rev Fr Endocrinol Clin; 1972; 13(4):339-61. PubMed ID: 4122472
[No Abstract] [Full Text] [Related]
14. [Simultaneous determination of thyreotropic hormone and long-acting thyroid stimulator in the plasma of Basedow patients].
Földes J; Gesztesi E; Takács I
Orv Hetil; 1970 Dec; 111(52):3067-70. PubMed ID: 4099957
[No Abstract] [Full Text] [Related]
15. [Study of the relationship between Basedow's disease and Hashimoto thyroiditis].
Földes J; Takó J; Bános C; Gesztesi E; Juhász J
Orv Hetil; 1971 Apr; 112(17):968-71. PubMed ID: 5108752
[No Abstract] [Full Text] [Related]
16. [A differential diagnosis: toxic adenoma or partial thyroid agenesis with Basedow's disease of the remaining lobe].
Mirouze J; Jaffiol C; Seignalet J; Pastorello R; Baldet L
Rev Fr Endocrinol Clin; 1967; 8(2):161-4. PubMed ID: 6072294
[No Abstract] [Full Text] [Related]
17. Long-acting thyroid stimulator (LATS) in toxic nodular goitre, toxic adenoma and Graves' disease.
Lamberg BA; Gordin A; Viherkoski M; Kvist G
Acta Endocrinol (Copenh); 1969 Oct; 62(2):199-209. PubMed ID: 5394703
[No Abstract] [Full Text] [Related]
18. Hyperthyroidism.
Wool MS
Major Probl Clin Surg; 1980; 15():102-19. PubMed ID: 7003266
[No Abstract] [Full Text] [Related]
19. [Abnormality and deficiency in cellular immunity and internal diseases--Basedow's disease and cellular immunity].
Shishiba Y
Nihon Rinsho; 1978; 36(5):960-6. PubMed ID: 353330
[No Abstract] [Full Text] [Related]
20. [Long-term evolution of immunologic and thyroid function in Graves disease according different therapeutic options].
Campos Pastor MM; Fernández Soto ML; Escobar-Jiménez F; Barredo Acedo F; Ruiz de Almodóvar M
Med Clin (Barc); 1994 Apr; 102(12):446-50. PubMed ID: 7516033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
